Peripheral Neuropathy
📧 Sign up to get email alerts when something new happens for Peripheral Neuropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-10-01Clinical Trial Update: Daratumumab for Polyneuropathy Associated With MGUS [Phase 2]
A Phase 2 trial of daratumumab for polyneuropathy associated with monoclonal gammopathy of undetermined significance has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-03-12Clinical Trial Update: Tai Chi Easy in Treating Cancer Survivors With Peripheral Sensory Neuropathy [NA]
The clinical trial investigating Tai Chi Easy for cancer survivors with peripheral sensory neuropathy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-02-28Clinical Trial Update: Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral Neuropathy
The clinical trial NCT02492360 that aimed to establish neuronal-like cells from patients with cisplatin-induced peripheral neuropathy has be…
-
CLINICAL_TRIALS withdrawal · 2017-07-12Clinical Trial Update: Pilot Study Investigating the Use of the ReBuilder to Treat Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer
A pilot study investigating the ReBuilder to treat chemotherapy-induced peripheral neuropathy in breast cancer patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-07-12Clinical Trial Update: L-glutamine Supplementation to Alleviate Symptoms of Taxane-Induced Neuropathy in Patients With Breast Cancer [Phase 1]
Phase 1 trial evaluating L-glutamine to alleviate taxane-induced neuropathy in breast cancer patients was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2016-03-08Clinical Trial Update: SINF: Peripheral Neuropathy in Cancer Survivors [Phase 1, Phase 2]
The SINF trial evaluating interventions for peripheral neuropathy in cancer survivors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-05-13Clinical Trial Update: Oral Thiamine for the Treatment of Painful Diabetic Peripheral Neuropathy [NA]
A clinical trial evaluating oral thiamine for painful diabetic peripheral neuropathy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2011-08-09Clinical Trial Update: Epoetin Alfa for HIV-Associated Neuropathy Trial [Phase 2]
The Phase 2 trial of epoetin alfa for HIV-associated neuropathy has been withdrawn.